MIST News & Events

The major averages closed broadly lower, with the S&P down over 1.5% and the Nasdaq falling over 2%, as investors continue to digest the Federal Reserve's more cautious stance on rate cuts while weighing ongoing volatility in energy markets. Traders continue to monitor the U.S.-Iran war, as Iran and Israel exchanged strikes overnight. Meanwhile, the Wall Street Journal reported that the Pentagon is sending thousands of extra Marines to the Middle East. Amid the continuing attacks, U.S. benchmark oil prices advanced again back near $100 per barrel.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:FedExprovided areport for Q3U.S. prosecutors indicted Super Microco-founder Wally Liaw and two others forNvidiachips to ChinaUnileveris in talks to separate its food business and combine it with McCormick,Nexstarhasof TegnaEcolabCoolIT Systems from KKRfor $4.75B in cash2. WALL STREET CALLS:Armto Buy at HSBC amid AI transitionOppenheimerFigsto Outperform on expectations for "sustained recovery"Chipotleto Outperform from Neutral at MizuhoMosaicto Neutral at BofA and to Sell at Freedom CapitalMagnum Ice Creamto Sell at Goldman Sachs3. AROUND THE WEB:Netflixand Warner Musichave reached a documentary partnership agreement, Deadline reportsKalshi's valuation hit $22B in an ongoing funding round, WSJ reportsNvidiaplans to sell 1M GPUs to Amazonby the end of 2027, Reuters reportsUBS'national bank charter has been approved by U.S. regulators, WSJ saysMetais reducing its reliance on outside content moderators, Bloomberg says4. MOVERS:Torridhigher afterand providing upbeat FY26 guidanceScholasticrises after reportingXPengfalls in New York afterFiscalNotelower afterand announcing it will lay off 25% of its staffFlowcoslips after its 7.8M5. EARNINGS/GUIDANCE:Milestone PharmaceuticalsreportedGemini Space StationreportedBitFuFureported a year-over-yearOndasprovidedIntellicheckreportedINDEXES:The Dow fell 443.96, or 0.96%, to 45,577.47, the Nasdaq lost 443.08, or 2.01%, to 21,647.61, and the S&P 500 declined 100.01, or 1.51%, to 6,506.48.

The major averages were broadly lower once again near noon as investors continue to digest the Federal Reserve's more cautious stance on rate cuts while weighing ongoing volatility in energy markets. Traders also continue to monitor the U.S.-Iran war, as Iran and Israel exchanged strikes overnight. Meanwhile, the Wall Street Journal reported that the Pentagon is sending thousands of extra Marines to the Middle East. Amid the continuing attacks, U.S. benchmark oil prices were higher, though still below $100 per barrel.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:FedExprovided areport for Q3U.S. prosecutors indicted Super Microco-founder Wally Liaw and two others forNvidiachips to ChinaUnileveris in talks to separate its food business and combine it with McCormick,Nexstarhasof TegnaEcolabCoolIT Systems from KKRfor $4.75B in cash2. WALL STREET CALLS:Armto Buy at HSBC amid AI transitionOppenheimerFigsto Outperform on expectations for "sustained recovery"Chipotleto Outperform from Neutral at MizuhoMosaicto Neutral at BofA and to Sell at Freedom CapitalMagnum Ice Creamto Sell at Goldman Sachs3. AROUND THE WEB:Kalshi's valuation hit $22B in an ongoing funding round, WSJ reportsNvidiaplans to sell 1M GPUs to Amazonby the end of 2027, Reuters reportsUBS'national bank charter has been approved by U.S. regulators, WSJ saysAmazon is developing a smartphone built around Alexa, Reuters saysMetais reducing its reliance on outside content moderators, Bloomberg says4. MOVERS:Torridhigher afterand providing upbeat FY26 guidanceScholasticrises after reportingXPengfalls in New York afterFiscalNotelower afterand announcing it will lay off 25% of its staffFlowcoslips after its5. EARNINGS/GUIDANCE:Milestone PharmaceuticalsreportedGemini Space StationreportedBitFuFureported a year-over-yearOndasprovidedand FY25IntellicheckreportedINDEXES:Near midday, the Dow was down 0.53%, or 244.36, to 45,777.07, the Nasdaq was down 1.10%, or 243.87, to 21,846.82, and the S&P 500 was down 0.78%, or 51.28, to 6,555.21.

Stock futures are modestly lower ahead of the open. Markets continue trading with a tentative and mixed tone as investors continue to digest the Federal Reserve's more cautious stance on rate cuts while monitoring ongoing volatility in energy markets.The macro backdrop remains defined by the interaction between monetary policy and energy prices. Oil has pulled back slightly after the sharp swings seen throughout the month, but crude is still trading at elevated levels following the geopolitical disruptions tied to the Middle East conflict. That dynamic continues to keep inflation expectations somewhat elevated, reinforcing the Federal Reserve's message that it can afford to remain patient before cutting rates. Investors are increasingly adjusting to the idea that the timing and magnitude of easing may be more limited than previously expected and equity markets are reflecting that recalibration.Currency and bond markets are also relatively steady, with yields holding near recent levels as traders reassess the outlook for inflation and growth in light of the recent oil shock.In pre-market trading, S&P 500 futures fell 0.38%, Nasdaq futures fell 0.54% and Dow futures fell 0.40%.Check out this morning's top movers from around Wall Street, compiled by The Fly.UP AFTER EARNINGS -Scholasticup 9%Milestone Pharmaceuticalsup 8%FedExup 7%Geminiup 4%DOWN AFTER EARNINGS -XPengdown 4%BitFuFudown 2%LOWER -Super Microdown 25% after the United States Attorney's Office for the Southern District of New York has unsealed an indictment of three individuals associated with the company in connection with an alleged conspiracy to commit export-control violationsEcolabdown 1% after entering into a definitive agreement to acquire CoolIT Systems for $4.75B in cash from funds managed by KKR

As of December 31, 2025, Milestone had cash, cash equivalents, and short-term investments of $106M, compared to $69.7M on December 31, 2024. "We are excited to see that our commercial launch of CARDAMYST and the initial engagement with providers, patients and payers is tracking or exceeding our pre-launch expectations," said Joseph Oliveto, president and CEO of Milestone Pharmaceuticals. "Our national sales force was fully deployed within eight weeks of our mid-December approval. Feedback from prescribers supports our belief that there is meaningful demand for a convenient, self-administered option to treat episodes of PSVT, and patient reactions to having CARDAMYST in hand is inspiring."